Recruiting

Buckeye Quit Stick

Sponsor:

Ohio State University Comprehensive Cancer Center

Code:

NCT07455513

Conditions

Cigarette Smoking-Related Carcinoma

Malignant Thoracic Neoplasm

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Electronic Health Record Review

Informational Intervention

Interview

Referral

Smoking Cessation Intervention

Study Details

Brief summary:

This clinical trial evaluates the feasibility of a novel tobacco cessation resource called a Buckeye Quit Stick among smokers with a diagnosed or suspected thoracic cancer. Tobacco use is the single most preventable cause of disease, disability, and death in the United States. While the benefits of quitting smoking are numerous, rates of persistent smoking after cancer diagnosis remain high. Research has found that patients who quit smoking but subsequently relapse frequently report the hand/oral habit as a barrier to sustained smoking cessation. The Buckeye Quit Stick is an innovative cessation aid designed to directly address patients' hand/oral habit by substituting the cessation aid for cigarettes without integrating pharmacologic intervention, which is typically managed by their medical provider and may require direct supervision due to the patient's health status. The Buckeye Quit Stick is designed to satisfy the repeated hand/oral pattern or ritual, thereby avoiding the physical loss of holding a cigarette in the hand or mouth and the action of smoking. It may also help occupy fidgeting hands and potentially reduce stress and cravings. This novel cessation resource may address key factors that influence smoking abstinence and improve patients' health outcomes.

Conditions

Cigarette Smoking-Related Carcinoma

Malignant Thoracic Neoplasm

Study ID

NCT07455513

Start date

Feb 25, 2026

Status verified date

Jun, 2026

Completion date

Mar 31, 2027

Anticipated

Primary completion date

Mar 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • >= 21 years old
  • Speak and understand English
  • Established patient of the OSU thoracic clinics
  • Diagnosed with a thoracic malignancy or has a clinically suspected thoracic malignancy as documented by treating provider
  • Willing and able to participate in the study protocol (e.g., complete the survey and related study documents and provide informed consent)
  • Current self-reported smoker
  • Willingness to change = score of above 1 on the Stages of Change measure

Exclusion Criteria:

  • < 21 years old (Ohio is a tobacco 21 state.)
  • Patient outside of the OSU clinics (This intervention targets patients who may benefit the most from cessation.)
  • Unwilling or unable to provide consent or complete study components
  • Prisoners will be excluded from participation

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Single group

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Prevention (Buckeye Quit Stick)

Patients receive a Buckeye Quit Stick and a smoking cessation informational packet on study. Patients also receive a referral to the James CCC smoking cessation clinic on study.

Interventions

Electronic Health Record Review

Ancillary studies

Informational Intervention

Receive smoking cessation information

Interview

Ancillary studies

Referral

Receive referral

Smoking Cessation Intervention

Receive Buckeye Quit Stick

Survey Administration

Ancillary studies

Primary outcome measure

  • Recruitment rates (feasibility) [ Time Frame: Up to 1 year ]
  • Adherence (feasibility) [ Time Frame: at baseline, 2 weeks, 3 months and 6 months ]
  • Retention rates (feasibility) [ Time Frame: At 2 weeks, 3 months, and 6 months ]

Central Contacts and Locations

Central contacts

The Ohio State University Comprehensive Cancer Center

800-293-5066OSUCCCClinicaltrials@osumc.edu

Locations

Ohio State University Comprehensive Cancer Center

Recruiting

Columbus, Ohio, United States, 43210

Contacts

Principal Investigator:

Logan Roof, MD, MS

More Information

Sponsor

Ohio State University Comprehensive Cancer Center

Last update posted

Jun 15, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2026-06-15.